P

Pathway Therapeutics Ltd

50 employees

Pathway Therapeutics develops selective inhibitors of PI3-kinase for the treatment of cancer and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

PI3K/mTOR Pathway Inhibitors
Biotechnology
Medical Device
Oncology Drug Development
Therapeutics
Cancer Biology

Date founded

2008

Funding rounds raised

Total raised

$9.6M

from 4 investors over 4 rounds

P

Pathway Therapeutics Ltd raised $7.5M on May 25, 2011

Investors: GBS Venture Partners

P

Pathway Therapeutics Ltd raised $4.5M on August 10, 2010

Investors: GBS Venture Partners

P

Pathway Therapeutics Ltd raised $2.4M on October 9, 2009

Investors: GBS Venture Partners

P

Pathway Therapeutics Ltd raised $9.6M on June 18, 2008

Investors: GBS Venture Partners

FAQ